Meprobamate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Meprobamate.
| Product ID | 51672-4147_3ca1984e-69f7-4fc5-9184-3843d737e518 |
| NDC | 51672-4147 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Meprobamate |
| Generic Name | Meprobamate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-05-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA200998 |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | MEPROBAMATE |
| Active Ingredient Strength | 200 mg/1 |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-05-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA200998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-05-23 |
| Marketing Category | ANDA |
| Application Number | ANDA200998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-05-23 |
| Marketing Category | ANDA |
| Application Number | ANDA200998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-05-23 |
| Ingredient | Strength |
|---|---|
| MEPROBAMATE | 200 mg/1 |
| SPL SET ID: | 4a9ad4f6-6826-4cb8-a097-2d2ea2c91d8b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 46708-019 | MEPROBAMATE | MEPROBAMATE |
| 46708-020 | MEPROBAMATE | MEPROBAMATE |
| 51672-4147 | Meprobamate | Meprobamate |
| 51672-4148 | Meprobamate | Meprobamate |
| 52549-4147 | Meprobamate | Meprobamate |
| 52549-4148 | Meprobamate | Meprobamate |
| 55111-640 | Meprobamate | Meprobamate |
| 55111-641 | Meprobamate | Meprobamate |
| 62332-019 | Meprobamate | Meprobamate |
| 62332-020 | Meprobamate | Meprobamate |
| 69097-974 | Meprobamate | Meprobamate |
| 69097-975 | Meprobamate | Meprobamate |